TBC1D3B Antibodies

Santa Cruz Biotechnology offers a broad range of TBC1D3B monoclonal antibodies for investigating TBC1D3B's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TBC1D3B belongs to the TBC (Tre-2/Bub2/CDC16) domain family and plays a vital role in regulating cellular signaling pathways and vesicle trafficking. Research has shown TBC1D3B's involvement in insulin signaling and glucose homeostasis, making it particularly relevant for metabolic studies. Scientists investigating TBC1D3B can gain valuable insights into conditions such as obesity and diabetes. Exploring TBC1D3B's functions helps reveal its impact on cellular regulation and disease development. Understanding TBC1D3B's mechanisms can lead to potential therapeutic strategies for metabolic disorders. Current research continues to uncover new aspects of TBC1D3B's biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TBC1D3B's role in health and disease.